We review the best free-stand mixers, from Salter to SMEG, to see which is the best for cake batter and beyond ...

UBS analyst Jon Windham lowered the firm’s price target on Stem (STEM) to 60c from $1 and keeps a Buy rating on the shares post the Q3 report. The firm says Stem is pivoting its business away from ...

Announced that the Phase 1 open label trial evaluating briquilimab as a second-line therapy in patients with LR-MDS demonstrated that briquilimab was able to deplete diseased hematopoietic stem cells ...

The USS Texas (BB-35), a storied battleship that served in both World Wars, faces an uncertain future. Despite a recent $60 ...